Expression and effects of high-mobility group box 1 in cervical cancer

International Journal of Molecular Sciences

Volumn 15, Issue 5, 2014, Pages 8699-8712

  Pang, Xiaoao ^a   Zhang, Yao ^a   Wei, Heng ^a   Zhang, Jing ^a   Luo, Qingshuang ^a   Huang, Chenglin ^a   Zhang, Shulan ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Cervical cancer; Forkhead winged helix transcription factor p3 (Foxp3); High mobility group box 1 protein (HMGB1); Immunosuppression; Regulatory T cells (Tregs); Serum squamous cell carcinoma antigen (SCC ag)

Indexed keywords

COMPLEMENT COMPONENT C5A RECEPTOR; CYTOKINE; GELATINASE B; HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE; SQUAMOUS CELL CARCINOMA ANTIGEN; TOLL LIKE RECEPTOR; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DENDRITIC CELL; DOWN REGULATION; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNORADIOMETRIC ASSAY; IMMUNOSUPPRESSIVE TREATMENT; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; ONCOGENE RAS; PAPILLOMAVIRUS INFECTION; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; TH1 CELL; TH2 CELL; UPREGULATION; UTERINE CERVIX CANCER; CANCER STAGING; FEMALE; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX TUMOR; YOUNG ADULT;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HMGB1 PROTEIN; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-10; INTERLEUKIN-2; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; NEOPLASM STAGING; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84900853755     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms15058699     Document Type: Article

References (30)

1. Hao, Q.; Du, X.Q.; Fu, X.; Tian, J. Expression and clinical significance of HMGB1 and RAGE in cervical squamous cell carcinoma. Zhonghua Zhong Liu Za Zhi 2008, 30, 292-295.
2. Thomas, J.O.; Travers, A.A. HMG1 and 2, and related "architectural" DNA-binding proteins. Trends Biochem. Sci. 2001, 26, 167-174.
3. Sims, G.P.; Rowe, D.C.; Rietdijk, S.T.; Herbst, R.; Coyle, A.J. HMGB1 and RAGE in inflammation and cancer. Annu. Rev. Immunol. 2010, 28, 367-388.
4. Tang, D.; Kang, R.; Livesey, K.M.; Cheh, C.W.; Farkas, A.; Loughran, P.; Hoppe, G.; Bianchi, M.E.; Tracey, K.J.; Zeh, H.J III; et al. Endogenous HMGB1 regulates autophagy. J. Cell Biol. 2010, 190, 881-892.
5. Volp, K.; Brezniceanu, M.L.; Bosser, S.; Brabletz, T.; Kirchner, T.; Gottel, D.; Joos, S.; Zörnig, M. Increased expression of high mobility group box 1(HMGB1) is associated with an elevated level of the antiapoptotic c-IAP2 protein in human colon carcinomas. Gut 2006, 55, 234-242.
6. Brezniceanu, M.L.; Volp, K.; Bosser, S.; Solbach, C.; Lichter, P.; Joos, S.; Zörnig, M. HMGB1 inhibits cell death in yeast and mammalian cells and is abundantly expressed in human breast carcinoma. FASEB J. 2003, 17, 1295-1297.
7. Cheng, B.Q.; Jia, C.Q.; Liu, C.T.; Lu, X.F.; Zhong, N.; Zhang, Z.L.; Fan, W.; Li, Y.Q. Serum high mobility group box chromosomal protein 1 is associated with clinicopathologic features in patients with hepatocellular carcinoma. Dig. Liver Dis. 2008, 40, 446-452.
8. Takada, M.; Hirata, K.; Ajiki, T.; Suzuki, Y.; Kuroda, Y. Expression of receptor for advanced glycation end products (RAGE) and MMP-9 in human pancreatic cancer cells. Hepatogastroenterology 2004, 51, 928-930.
9. Kuniyasu, H.; Chihara, Y.; Kondo, H.; Ohmori, H.; Ukai, R. Amphoterin induction in prostatic stromal cells by androgen deprivation is associated with metastatic prostate cancer. Oncol. Rep. 2003, 10, 1863-1868.
10. Sheng, X.; Du, X.; Zhang, X.; Li, D.; Lu, C.; Li, Q.; Ma, Z.; Song, Q.; Wang, C. Clinical value of serum HMGB1 levels in early detection of recurrent squamous cell carcinoma of uterine cervix: Comparison with serum SCCA, CYFRA21-1, and CEA levels. Croat. Med. J. 2009, 50, 455-464.
11. Sakaguchi, S.; Miyara, M.; Costantino, C.M.; Hafler, D.A. FOXP3+ regulatory T cells in the human immune system. Nat. Rev. Immunol. 2010, 10, 490-500.
12. Molling, J.W.; de Gruijl, T.D.; Glim, J.; Moreno, M.; Rozendaal, L.; Meijer, C.J.L.M.; van den Eertwegh, A.J.M.; Scheper, R.J.; von Blomberg, M.E.; Bontke, H.J. CD4+CD25hi regulatory T-cell frequency correlates with persistence of human papillomavirus type 16 and T helper cell responses in patients with cervical intraepithelial neoplasia. Int. J. Cancer 2007, 121, 1749-1755.
13. Liu, Z.; Falo, L.D., Jr.; You, Z. Knockdown of HMGB1 in tumor cells attenuates their ability to induce regulatory T cells and uncovers naturally acquired CD8 T cell-dependent antitumor immunity. J. Immunol. 2011, 187, 118-125.
14. Huang, L.F.; Yao, Y.M.; Zhang, L.T.; Dong, N.; Yu, Y.; Sheng, Z.Y. The effect of high-mobility group box 1 protein on activity of regulatory T cells after thermal injury in rats. Shock 2009, 31, 322-329.
15. Zhang, Y.; Yao, Y.; Huang, L.; Dong, N.; Yu, Y.; Sheng, Z. The Potential Effect and Mechanism of High-Mobility Group Box 1 Protein on Regulatory T Cell-Mediated Immunosuppression. J. Interf. Cytokine Res. 2011, 31, 249-257.
16. Jeong, B.K.; Choi, D.H.; Huh, S.J.; Park, W.; Bae, D.S.; Kim, B.G. The role of squamous cell carcinoma antigen as a prognostic and predictive factor in carcinoma of uterine cervix. Radiat. Oncol. J. 2011, 29, 191-198.
17. Foell, D.; Wittkowski, H.; Roth, J. Mechanisms of disease: A 'DAMP' view of inflammatory arthritis. Nat. Rev. Rheumatol. 2007, 3, 382-390.
18. Gilmore, T.D.; Koedood, M.; Piffat, K.A.; White, D.W. Rel/NF-κB/lκB proteins and cancer. Oncogene 1996, 13, 1367-1378.
19. Chen, Y.; Li, R.; Wang, R.; Liu, Z. The significance of nuclear factor kappa B p65 expression on the vascular endothelial cells of rectum adnocarcinoma of human. Hua Xi Yi Ke Da Xue Xue Bao 2001, 32, 196-199.
20. O-charbenrat, P.; Wongkajomsil, P.A.; Phys-Evans, P.H.; Eccles, S.A. Signaling pathways required for matrix metalloproteinase-9 induction by betacelluin in head-and-neck squamous carcinoma cells. Int. J. Cancer 2004, 111, 174-183.
21. Wang, Z.; Larregina, A.T.; Shufesky, W.J.; Perone, M.J.; Montecalvo, A.; Zahorchak, A.F.; Thomson, A.W.; Morelli, A.E. Use of the inhibitory effete of apoptotic cells on dendritic cells for graft survival via T-cell deletion and regulatory T cells. Am. J. Transplant. 2006, 6, 1297-1311.
22. Hazzalin, C.A.; Mahadevan, L.C. MAPK-regulated transcription: A continuously variable gene switch? Nat. Rev. Mol. Cell Biol. 2002, 3, 30-40.
23. Arrighi, J.F.; Rebsamen, M.; Rousset, F.; Kindler, V.; Hauser, C. A critical role for p38 mitogen-activated protein kinase in the maturation of human blood-derived dendritic cells induced by lipopolysaccharide, TNF-alpha, and contact sensitizers. J. Immunol. 2001, 166, 3837-3845.
24. Kusume, A.; Sasahira, T.; Luo, Y.; Isobe, M.; Nakagawa, N.; Tatsumoto, N.; Fujii, K.; Ohmori, H.; Kuniyasu, H. Suppression of dendritic cells by HMGB1 is associated with lymph node metastasis of human colon cancer. Pathobiology 2009, 76, 155-162.
25. Dumitriu, I.E.; Baruah, P.; Valentinis, B.; Voll, R.E.; Herrmann, M.; Nawroth, P.P.; Arnold, B.; Bianchi, M.E.; Manfredi, A.A.; Rovere-Querini, P. Release of high mobility group box1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products. J. Immunol. 2005, 174, 7506-7515.
26. Rovere-Querini, P.; Capobianco, A.; Scaffidi, P.; Valentinis, B.; Catalanotti, F.; Giazzon, M.; Dumitriu, I.E.; Müller, S.; Iannacone, M.; Traversari C. et al. HMGB1 is an endogenous immune adjuvant released by necrotic cells. EMBO Rep. 2004, 5, 825-830.
27. Ishii, K.J.; Coban, C.; Akira, A. Manifold meehanisms of Toll-like receptor-ligand recognition. J. Clin. Immunol. 2005, 25, 511-521.
28. DeMarco, R.A.; Fink, M.P.; Lotze, M.T. Monocytes promote natural killer cell interferon gamma production in response to endogenous danger signal HMGB 1. Mol. Immunol. 2005, 42, 433-444.
29. Gaarenstroom, K.N.; Kenter, G.G.; Bonfrer, J.M.G.; Korse, C.M.; van deVijver, M.J.; Fleuren, G.-J.; Trimbos, J.B. Can initial serum cyfra 21-1, SCC antigen, and TPA levels in squamous cell cervical cancer predict lymph node metastases or prognosis? Gynecol. Oncol. 2000, 77, 164-170.
30. Ohara, K.; Tanaka, Y.; Tsunoda, H.; Nishida, M.; Sugahara, S.; Itai, Y. Assessment of cervical cancer radio response by serum squamous cell carcinoma antigen and magnetic resonance imaging. Obstet. Gynecol. 2002, 100, 781-787.